JP2014527989A - Microemulsion containing button extract and its preparation method and application - Google Patents
Microemulsion containing button extract and its preparation method and application Download PDFInfo
- Publication number
- JP2014527989A JP2014527989A JP2014532216A JP2014532216A JP2014527989A JP 2014527989 A JP2014527989 A JP 2014527989A JP 2014532216 A JP2014532216 A JP 2014532216A JP 2014532216 A JP2014532216 A JP 2014532216A JP 2014527989 A JP2014527989 A JP 2014527989A
- Authority
- JP
- Japan
- Prior art keywords
- button
- microemulsion
- extract
- button extract
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 55
- 239000004530 micro-emulsion Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 206010040880 Skin irritation Diseases 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 230000009759 skin aging Effects 0.000 claims description 3
- 230000036556 skin irritation Effects 0.000 claims description 3
- 231100000475 skin irritation Toxicity 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 239000000047 product Substances 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 12
- 239000000203 mixture Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- RTBWWWVNZWFNBV-SFHVURJKSA-N (2s)-3-phenyl-2-(undec-10-enoylamino)propanoic acid Chemical compound C=CCCCCCCCCC(=O)N[C@H](C(=O)O)CC1=CC=CC=C1 RTBWWWVNZWFNBV-SFHVURJKSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000017278 Glutaredoxin Human genes 0.000 description 2
- 108050005205 Glutaredoxin Proteins 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102000001639 Thioredoxin Reductase 1 Human genes 0.000 description 2
- 108010093836 Thioredoxin Reductase 1 Proteins 0.000 description 2
- 244000225942 Viola tricolor Species 0.000 description 2
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
- 102000004363 Aquaporin 3 Human genes 0.000 description 1
- 108090000991 Aquaporin 3 Proteins 0.000 description 1
- 102100035904 Caspase-1 Human genes 0.000 description 1
- 108090000426 Caspase-1 Proteins 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 1
- PCDQPRRSZKQHHS-CCXZUQQUSA-N Cytarabine Triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-CCXZUQQUSA-N 0.000 description 1
- 102100037709 Desmocollin-3 Human genes 0.000 description 1
- 101710157874 Desmocollin-3 Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241001355281 Hibbertia scandens Species 0.000 description 1
- 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 description 1
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Abstract
【課題】 ボタン抽出物を含むマイクロエマルション及びその調製方法と応用を提供することを課題とする。【解決手段】 ボタン抽出物を含むマイクロエマルションの調製方法に関し、ボタン抽出物と水の重量比が1:5〜1:12で、ボタン抽出物と、水、水添レシチン及び油相とを混合し、混合後の水添レシチンの濃度が1wt%〜50wt%で、50〜500atm下で、100〜800m/sのずり速度で10〜60分混合する。この方法で得たマイクロエマルションは安定性が良く、使いやすく、化粧品やスキンケア用品の製造に使用できる。【選択図】 なしPROBLEM TO BE SOLVED: To provide a microemulsion containing a button extract and a preparation method and application thereof. SOLUTION: A method for preparing a microemulsion containing a button extract, wherein the button extract is mixed with water, hydrogenated lecithin and an oil phase at a weight ratio of 1: 5 to 1:12. The mixed hydrogenated lecithin is mixed at a shear rate of 100 to 800 m / s for 10 to 60 minutes under a concentration of 1 to 50 wt% and 50 to 500 atm. The microemulsion obtained by this method has good stability, is easy to use, and can be used for the production of cosmetics and skin care products. [Selection figure] None
Description
本発明は、植物抽出物に関し、特に、遺伝子の調節に用い、また化粧品にも用いることができるボタン抽出物を含むマイクロエマルションに関する。 The present invention relates to plant extracts, and in particular to microemulsions containing button extracts that can be used for gene regulation and also in cosmetics.
ボタンは、伝統的な漢方薬材であり、中国薬学大典の記載によると、ボタンの根、葉、花も漢方薬にすることができる。美容スキンケア面における運用も年代をさかのぼることができ、例えば《外台秘要方》《御院要方》等といった古書内にボタンの皮やボタンの花等のスライスを含有した美容処方が記載されている。 The button is a traditional Chinese medicine, and according to the description of the Chinese Pharmacy, the roots, leaves and flowers of the button can also be used as a Chinese medicine. The operation in the beauty skin care aspect can also be traced back to the age. For example, beauty prescriptions containing button skins, button flower slices, etc. are written in old books, such as 《Outside Secret Secretary》 and 《Gion Essentials》. ing.
現在もボタンは、シャンプー(特許文献1)や美白クリーム(特許文献2)等の洗浄化粧品に活用されているが、その抽出工程、安定性の保護、効果検証等の面においていずれも欠陥が存在している。 The button is still used for cleaning cosmetics such as shampoo (Patent Document 1) and whitening cream (Patent Document 2), but there are defects in the extraction process, stability protection, effect verification, etc. doing.
ボタンの油溶性と水溶性の抽出物は、異なる効果を持ち、その溶解性も異なるため、化粧品或いはスキンケア用品の配合内に同時に加えることが困難となっている。若しくは化粧品とスキンケア用品を調製するプロセスにおいてそれぞれ異なるステップ内で加えなければならない。 Button oil-soluble and water-soluble extracts have different effects and differ in solubility, making it difficult to add simultaneously to the formulation of a cosmetic or skin care product. Or they must be added in different steps in the process of preparing cosmetics and skin care products.
本発明は、システム的な工程と検証方法を設計することで、ボタンの有効成分を全面的に抽出し、また物理的技術を利用して安定性を保護することで、化粧品への活用の便宜性が図られると共に、DNAマイクロアレイ技術でボタン抽出物とその他の効能物質の遺伝子調節面における働きを迅速且つ正確的に確認でき、また最適配合範囲を見付け出すことができることにある。 The present invention is designed for systematic processes and verification methods to extract all the active ingredients of buttons, and to protect the stability by using physical technology to facilitate the use in cosmetics. In addition, the DNA microarray technology can quickly and accurately confirm the action of the button extract and other active substances on the gene regulation surface, and can find the optimum blending range.
本発明は、ボタン抽出物を含むマイクロエマルション及びその調製方法を提供することを目的とする。 It is an object of the present invention to provide a microemulsion containing a button extract and a method for preparing the same.
本発明は、上記のボタン抽出物を含むマイクロエマルションを遺伝子制御複合体の調製に用いるものである。 The present invention uses a microemulsion containing the above button extract for the preparation of a gene regulatory complex.
本発明は、上記のボタン抽出物を含むマイクロエマルションを化粧品やスキンケア用品の製造にことをもう一つの目的とする。 Another object of the present invention is to produce a microemulsion containing the above button extract for the production of cosmetics and skin care products.
ボタン抽出物と水の重量比が1:5〜1:12で、ボタン抽出物と、水、水添レシチン及び油相とを混合し、混合後の水添レシチンの濃度が1wt%〜50wt%で、油相の濃度が1wt%〜50wt%で、50〜500atm下で100〜800m/sのずり速度で10〜60分混合する。 The weight ratio of the button extract to water is 1: 5 to 1:12, and the button extract, water, hydrogenated lecithin and oil phase are mixed, and the concentration of hydrogenated lecithin after mixing is 1 wt% to 50 wt%. Then, the concentration of the oil phase is 1 wt% to 50 wt%, and the mixture is mixed for 10 to 60 minutes at a shear rate of 100 to 800 m / s under 50 to 500 atm.
油相は、シリコンオイル、鉱物油及び水添ポリイソブテンのいずれかから選ぶことができる。 The oil phase can be selected from any of silicon oil, mineral oil and hydrogenated polyisobutene.
ボタン抽出物の調製方法は、ボタン(根、茎、葉、花を含む)の水分の含有量を<10%まで乾燥させ、30〜50メッシュまで粉砕する工程(1)と、石油エーテル、ノルマルヘキサン或いはエタノールを用い、摂氏30〜90度で2〜8時間をかけて固液分離で抽出する工程(2)と、液体部分の溶剤を回収(溶媒残留量<0.1%)してボタンの油溶性成分を得て、摂氏30〜90度で1〜4時間をかけて固液分離で固体残渣用の水を抽出し、液体部分を濃縮して抽出物とし、ボタンの水溶性成分を得る工程(3)と、ボタンの油溶性成分と水溶性成分を混合する工程(4)と、を備える。 The method for preparing the button extract includes the step (1) of drying the water content of the button (including roots, stems, leaves and flowers) to <10% and crushing to 30-50 mesh, petroleum ether, normal Extraction by solid-liquid separation over 2-8 hours at 30-90 degrees Celsius using hexane or ethanol (2), and recovering the solvent in the liquid part (solvent residual amount <0.1%) and button The oil-soluble component is obtained, and water for solid residue is extracted by solid-liquid separation at 30 to 90 degrees Celsius for 1 to 4 hours, and the liquid part is concentrated to obtain an extract. A step (3) of obtaining, and a step (4) of mixing the oil-soluble component and the water-soluble component of the button.
上記の方法で得られるボタン抽出物を含むマイクロエマルションは、粒径1000〜2000nmで、ボタン抽出物の含有量は1%〜25%となる。 The microemulsion containing the button extract obtained by the above method has a particle size of 1000 to 2000 nm, and the content of the button extract is 1% to 25%.
このボタン抽出物を含むマイクロエマルションは、ボタンの水溶性成分と油溶性成分の抽出物を同時に含んでおり、スキンケア用品や化粧品の製造に用いることができ、また、一般のボタン抽出物と比べ、スキンケア用品や化粧品としての安定性が高い。このボタン抽出物を含むマイクロエマルションのスキンケア用品や化粧品での使用量は0.1wt%〜10wt%とする。 The microemulsion containing this button extract contains the extract of the water-soluble component and oil-soluble component of the button at the same time, and can be used for the manufacture of skin care products and cosmetics. High stability as skin care products and cosmetics. The amount of microemulsion containing the button extract used in skin care products and cosmetics is 0.1 wt% to 10 wt%.
このボタン抽出物を含むマイクロエマルションとその他の物質とで調合することで、メラニンを形成している遺伝子、皮膚の保湿能力と関係のある遺伝子、皮膚の老化の改善に関係する遺伝子及び皮膚への刺激の緩和に関係する遺伝子の発現量を調節することができる。 By blending this button extract with a microemulsion and other substances, genes that form melanin, genes that are related to the moisturizing ability of the skin, genes that are related to the improvement of skin aging, and to the skin It is possible to regulate the expression level of genes related to relaxation of stimulation.
本発明の利点は、ボタンの水溶性成分と油溶性成分をマイクロエマルションに調製し、安定性を高め、使いやすいことにある。このマイクロエマルションを使用し化粧品やスキンケア用品を製造すると、効果的に保湿し、メラニンを減らし、皮膚の老化を改善し、皮膚への刺激を緩和することができる。 An advantage of the present invention is that the water-soluble component and oil-soluble component of the button are prepared in a microemulsion to improve stability and ease of use. Using this microemulsion to produce cosmetics and skin care products can effectively moisturize, reduce melanin, improve skin aging, and alleviate skin irritation.
以下、本発明の特徴及び効果を更に明確に分かりやすくするため、実施例を添えて説明する。 Hereinafter, in order to make the features and effects of the present invention clearer and easier to understand, examples will be described along with examples.
ボタン(根、茎、葉、花を含む)の水分の含有量を<7%まで乾燥させ、20メッシュまで粉砕した。 The moisture content of the buttons (including roots, stems, leaves, flowers) was dried to <7% and ground to 20 mesh.
エタノールを溶剤として用い、摂氏60度で6時間をかけて固液分離で抽出した。液体部分を蒸留し溶剤を取り除き、その溶剤を回収(溶媒残留量<0.1%)してボタンの油溶性成分を得た。 Extraction was performed by solid-liquid separation using ethanol as a solvent at 60 degrees Celsius for 6 hours. The liquid portion was distilled to remove the solvent, and the solvent was recovered (residual solvent amount <0.1%) to obtain an oil-soluble component of the button.
摂氏70度で3時間をかけて固液分離で固体残渣用の水を抽出し、液体部分を濃縮して抽出物とし、ボタンの水溶性成分を得た。 Water for solid residue was extracted by solid-liquid separation at 70 degrees Celsius for 3 hours, and the liquid part was concentrated to obtain an extract, thereby obtaining a water-soluble component of the button.
ボタンの水溶性成分と油溶性成分を混合した。 The water-soluble component and oil-soluble component of the button were mixed.
エタノールは、石油エーテルやノルマルヘキサンを代替として用いることもでき、同様の結果を得られる。 Ethanol can be replaced with petroleum ether or normal hexane, and similar results can be obtained.
実施例1で得たボタンの油溶性成分と水溶性成分の混合物1kgに、10kgの水を入れた。さらに水添レシチン4kgとシリコンオイル5kgを加え混合液とした。水添レシチンとシリコンオイルの混合液における質量濃度はそれぞれ20%と25%とした。 10 kg of water was added to 1 kg of a mixture of the oil-soluble component and the water-soluble component of the button obtained in Example 1. Further, 4 kg of hydrogenated lecithin and 5 kg of silicon oil were added to obtain a mixed solution. The mass concentrations in the mixed solution of hydrogenated lecithin and silicone oil were 20% and 25%, respectively.
混合液をステンレス容器に入れ、500atmの圧力を加え、500m/sのずり速度で40min混合して、マイクロエマルションを形成し、ボタン抽出物を含むマイクロエマルションを得た。最終的な製品の粒径は1000〜2000nmの範囲で、そのボタン抽出物の含有量は5wt%とした。シリコンオイルは鉱物油を代替として用いることもでき、同様の結果を得られる。 The mixed solution was put into a stainless steel container, a pressure of 500 atm was applied, and the mixture was mixed at a shear rate of 500 m / s for 40 min to form a microemulsion, and a microemulsion containing a button extract was obtained. The final product particle size ranged from 1000 to 2000 nm and the button extract content was 5 wt%. Silicone oil can be replaced by mineral oil, with similar results.
上記の調製で得たマイクロエマルションを乳液とクリーム基質に加え、添加量10%の実験群とした。これと同時に、市販のマイクロエマルション化していないボタン抽出物を同様の乳液とクリーム基質に加え、添加量0.5%の対照群とした。何も加えない乳液とクリーム基質をブランクとした。 The microemulsion obtained by the above preparation was added to the emulsion and the cream substrate to form an experimental group with an addition amount of 10%. At the same time, a commercially available button extract that was not microemulsified was added to the same emulsion and cream substrate to form a control group with an addition amount of 0.5%. A milk and cream substrate with nothing added was blank.
実験群と対照群の試料を透明のプラスチック瓶に置き、24時間光を照射し、摂氏40度で4週間負荷テストを実施した。ブランクは日陰の涼しいところで保存した。40人のボランティアに色合い・においについて評価をしてもらった。すべてのボランティアが、実験群とブランクを比較し、「色合い・におい共に変化なし」または「色合い・においにごくわずか変化」と回答した。すべてのボランティアが、対照群とブランクを比較し、「色合い・におい共に大きな変化」と回答した。すべてのボランティアが、「実験群の外観とにおいは対照群より優れている」と回答した。 Samples from the experimental group and the control group were placed in transparent plastic bottles, irradiated with light for 24 hours, and subjected to a load test at 40 degrees Celsius for 4 weeks. The blank was stored in a cool shade. Forty volunteers evaluated the color and smell. All volunteers compared the experimental group with the blank and answered “no change in tint / smell” or “slight change in tint / smell”. All the volunteers compared the blank with the control group and answered, “A great change in both color and odor”. All volunteers replied that “the appearance and smell of the experimental group was superior to the control group”.
実施例1で得たボタンの油溶性成分と水溶性成分の混合物1.2kgに、7.8kgの水を入れた。さらに水添レシチン0.5kgとシリコンオイル0.5kgを加え混合液とした。水添レシチンとシリコンオイルの混合液における質量濃度はそれぞれ5%と5%とした。 7.8 kg of water was added to 1.2 kg of the mixture of the oil-soluble component and the water-soluble component of the button obtained in Example 1. Further, 0.5 kg of hydrogenated lecithin and 0.5 kg of silicon oil were added to obtain a mixed solution. The mass concentrations in the mixture of hydrogenated lecithin and silicone oil were 5% and 5%, respectively.
混合液をステンレス容器に入れ、5atmの圧力を加え、800m/sのずり速度で60min混合して、マイクロエマルションを形成し、ボタン抽出物を含むマイクロエマルションを得た。最終的な製品の粒径は1000〜2000nmの範囲で、そのボタン抽出物の含有量は12wt%とした。 The mixed solution was put into a stainless steel container, a pressure of 5 atm was applied, and the mixture was mixed at a shear rate of 800 m / s for 60 minutes to form a microemulsion to obtain a microemulsion containing a button extract. The final product particle size was in the range of 1000-2000 nm, and the button extract content was 12 wt%.
実施例1で得たボタンの油溶性成分と水溶性成分の混合物1.2kgに、7.8kgの水を入れた。さらに水添レシチン0.5kgと水添ポリイソブテン0.5kgを加え混合液とした。水添レシチンと水添ポリイソブテンの混合液における質量濃度はそれぞれ5%と5%とした。 7.8 kg of water was added to 1.2 kg of the mixture of the oil-soluble component and the water-soluble component of the button obtained in Example 1. Further, 0.5 kg of hydrogenated lecithin and 0.5 kg of hydrogenated polyisobutene were added to prepare a mixed solution. The mass concentrations in the mixed solution of hydrogenated lecithin and hydrogenated polyisobutene were 5% and 5%, respectively.
残りの手順は実施例3と同じで、ボタン抽出物を含むマイクロエマルションを得た。最終的な製品の粒径は1000〜2000nmの範囲で、そのボタン抽出物の含有量は12wt%とした。 The rest of the procedure was the same as in Example 3, and a microemulsion containing button extract was obtained. The final product particle size was in the range of 1000-2000 nm, and the button extract content was 12 wt%.
ヒト表皮角化細胞(HEK)の培養株を6ウェルプレートに接種し、その密度は約20000細胞/cm2であって、細胞の融合率が70%に達したとき、少なくとも2グループに分ける工程(1)。 When a human epidermal keratinocyte (HEK) culture is inoculated into a 6-well plate, the density is about 20000 cells / cm 2 , and when the cell fusion rate reaches 70%, dividing into at least two groups (1).
このうちの1つにボタン抽出物を含む有効成分を加えて24時間処理する。実施例3または4のボタン抽出物を含むマイクロエマルションとウンデシレノイルフェニルアラニン(SEPPIC社の製品)を加え、DMEMを使用して希釈し、最終的に細胞系の中のボタン抽出物を含むマイクロエマルションの濃度を3wt%、ウンデシレノイルフェニルアラニンを1wt%とし、もう1つを対照とする(ブランク培地を加える)工程(2)。 One of these is added with an active ingredient containing button extract and treated for 24 hours. Add the microemulsion containing the button extract of Example 3 or 4 and undecylenoylphenylalanine (product of SEPPIC), dilute using DMEM and finally the microemulsion containing the button extract in the cell line Step (2) in which the concentration of the solution is 3 wt%, undecylenoylphenylalanine is 1 wt%, and the other is the control (add blank medium).
細胞を集めてからRNAを単離させ、RNAをcDNAに形質転換し、これにより得られたcDNAをT7RNAポリメラーゼにより増幅し、アントシアニン−3或いはアントシアニン−5の蛍光標識を使用してシチジン三リン酸を標識し、標識したcDNAをDNAマイクロアレイのスライドガラス上にハイブリダイゼーションし、Agilentのデュアルチャネルレーザー検出DNAマイクロアレイスキャナシステムを使用してDNAマイクロアレイのスライドガラスをスキャンし、Cy3標識のレーザー波長は532nmとし、Cy5標識のレーザー波長は633nmとして、蛍光強度を記録し、データ分析を行う工程(3)。 After collecting the cells, RNA is isolated, RNA is transformed into cDNA, the resulting cDNA is amplified with T7 RNA polymerase, and cytidine triphosphate using anthocyanin-3 or anthocyanin-5 fluorescent labels The labeled cDNA is hybridized onto a DNA microarray slide, and the DNA microarray slide is scanned using Agilent's dual channel laser detection DNA microarray scanner system. The laser wavelength for Cy3 labeling is 532 nm. The laser wavelength of Cy5 label is 633 nm, the fluorescence intensity is recorded, and data analysis is performed (3).
その結果、GM−CSF(発現を20倍引き下げる)、グルタレドキシン(発現を38倍引き上げる)、チオレドキシン還元酵素1(発現を24倍引き上げる)など、メラニン形成と関係のある遺伝子の発現量を効果的に調節することができた。 As a result, GM-CSF (reducing expression 20 times), glutaredoxin (raising expression 38 times), thioredoxin reductase 1 (raising expression 24 times), etc. Could be adjusted.
細胞の培養と検出方法は実施例5と同じで、工程(2)において実施例3或いは実施例4のボタン抽出物を含むマイクロエマルションとビタミンCを加え、最終的に細胞系の中のボタン抽出物を含むマイクロエマルションの濃度を3wt%、ビタミンCを0.5wt%とする。 The cell culture and detection method is the same as in Example 5. In step (2), the microemulsion containing the button extract of Example 3 or Example 4 and vitamin C are added, and finally the button is extracted from the cell line. The concentration of the microemulsion containing the product is 3 wt% and vitamin C is 0.5 wt%.
その結果、GM−CSF(発現を30倍引き下げる)、グルタレドキシン(発現を16倍引き上げる)、チオレドキシン還元酵素1(発現を10倍引き上げる)など、メラニン形成と関係のある遺伝子の発現量を効果的に調節することができた。 As a result, GM-CSF (reducing expression 30 times), glutaredoxin (raising expression 16 times), thioredoxin reductase 1 (raising expression 10 times), and the like, the expression level of genes related to melanogenesis is effectively reduced. Could be adjusted.
細胞の培養と検出方法は実施例5と同じで、工程(2)において実施例3或いは実施例4のボタン抽出物を含むマイクロエマルションとパンジー抽出物(フランスSilab社の製品)を加え、最終的に細胞系の中のボタン抽出物を含むマイクロエマルションの濃度を1wt%、パンジー抽出物を1wt%とする。 The cell culture and detection method was the same as in Example 5. In step (2), the microemulsion containing the button extract of Example 3 or Example 4 and the pansy extract (product of Silab, France) were added. The concentration of the microemulsion containing the button extract in the cell line is 1 wt%, and the pansy extract is 1 wt%.
その結果、Desmocollin3(発現を18倍引き上げる)、Filaggrin(発現を4倍引き上げる)、AQP3(発現を2倍引き上げる)など、皮膚の保湿能力と関係のある遺伝子の発現量を効果的に調節することができた。 As a result, effectively regulate the expression level of genes related to skin moisturizing ability, such as Desmocollin3 (Raise expression 18 times), Filagrin (Raise expression 4 times), AQP3 (Raise expression 2 times) I was able to.
細胞の培養と検出方法は実施例5と同じで、工程(2)において実施例2のボタン抽出物を含むマイクロエマルションとイノンド抽出物(BASF製品)を加え、最終的に細胞系の中のボタン抽出物を含むマイクロエマルションの濃度を3wt%、イノンド抽出物を1wt%とする。 The cell culture and detection method is the same as in Example 5. In step (2), the microemulsion containing the button extract of Example 2 and Inond extract (BASF product) are added, and finally the button in the cell line is added. The concentration of the microemulsion containing the extract is 3 wt%, and the inondo extract is 1 wt%.
その結果、MMP1(発現を30%引き下げる)、MMP2(発現を90%引き下げる)、LOXL−8(発現を2倍引き上げる)、COL1A2(発現を60%引き上げる)など、皮膚の老化の改善と関係のある遺伝子の発現量を効果的に調節することができた。 As a result, MMP1 (reducing expression by 30%), MMP2 (reducing expression by 90%), LOXL-8 (raising expression by 2 times), COL1A2 (raising expression by 60%), etc. The expression level of a gene could be effectively controlled.
細胞の培養と検出方法は実施例5と同じで、工程(2)において実施例2のボタン抽出物を含むマイクロエマルションとグリチルリチン酸ジカリウムとビサボロールを加え、最終的に細胞系の中のボタン抽出物を含むマイクロエマルションの濃度を1.5wt%、グリチルリチン酸ジカリウムを0.5wt%、ビサボロールを0.5wt%とする。 The cell culture and detection method was the same as in Example 5. In step (2), a microemulsion containing the button extract of Example 2, dipotassium glycyrrhizinate and bisabolol was added, and finally the button extract in the cell line. The concentration of the microemulsion containing 1.5 wt%, dipotassium glycyrrhizinate 0.5 wt%, and bisabolol 0.5 wt%.
その結果、IL−18(発現を90%引き下げる)、Caspase1(発現を4倍引き下げる)など、皮膚への刺激の緩和と関係のある遺伝子の発現量を効果的に調節することができた。 As a result, it was possible to effectively regulate the expression level of genes such as IL-18 (reducing expression by 90%), Caspase1 (reducing expression by 4 times), and the like, which are related to relaxation of skin irritation.
実施例10から15はそれぞれ実施例2から4で得たボタン抽出物を含むマイクロエマルションを使用して、クレンジング製品、美容製品、クリーム製品及び化粧水の製造に用いる。 Examples 10 to 15 are used for the production of cleansing products, beauty products, cream products and lotions using the microemulsions containing the button extracts obtained in Examples 2 to 4, respectively.
クレンジング製品の調製 Preparation of cleansing products
美容製品の調製 Beauty product preparation
クリーム製品の調製 Cream product preparation
クリーム製品の調製2 Cream product preparation 2
化粧水の調製 Preparation of lotion
乳液の調製 Preparation of emulsion
Claims (7)
石油エーテル、ノルマルヘキサン或いはエタノールを用い、摂氏30〜90度で2〜8時間をかけて固液分離で抽出する工程(2)と、
液体部分の溶剤を回収(溶媒残留量<0.1%)してボタンの油溶性成分を得て、摂氏30〜90度で1〜4時間をかけて固液分離で固体残渣用の水を抽出し、液体部分を濃縮して抽出物とし、ボタンの水溶性成分を得る工程(3)と、
ボタンの油溶性成分と水溶性成分を混合する工程(4)と、
を備えることを特徴とする、請求項1に記載のボタン抽出物を含むマイクロエマルションの調製方法。 (1) drying the button moisture content to <10% and crushing to 30-50 mesh;
(2) a step of extracting by solid-liquid separation using petroleum ether, normal hexane or ethanol at 30 to 90 degrees Celsius for 2 to 8 hours;
The solvent in the liquid part is recovered (solvent residual amount <0.1%) to obtain an oil-soluble component of the button, and water for solid residue is obtained by solid-liquid separation at 30 to 90 degrees Celsius for 1 to 4 hours. Extracting and concentrating the liquid portion into an extract to obtain a water-soluble component of the button (3);
A step (4) of mixing the oil-soluble component and the water-soluble component of the button;
A method for preparing a microemulsion comprising a button extract according to claim 1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110296131.5 | 2011-09-30 | ||
CN201110296131.5A CN103027863B (en) | 2011-09-30 | 2011-09-30 | Microemulsion containing peony extracts as well as preparation method and application of microemulsion |
PCT/CN2012/000379 WO2013044579A1 (en) | 2011-09-30 | 2012-03-27 | Microemulsion containing peony extract, preparation method therefor and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014527989A true JP2014527989A (en) | 2014-10-23 |
JP5963868B2 JP5963868B2 (en) | 2016-08-03 |
Family
ID=47994202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014532216A Active JP5963868B2 (en) | 2011-09-30 | 2012-03-27 | Microemulsion containing button extract and its preparation method and application |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5963868B2 (en) |
CN (1) | CN103027863B (en) |
WO (1) | WO2013044579A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113164366A (en) * | 2018-11-19 | 2021-07-23 | 株式会社Lg生活健康 | Composition for stabilizing poorly soluble component and cosmetic composition containing same |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL248148B (en) | 2016-09-29 | 2021-09-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Method for extraction of an agent from a plant source |
IL248150B (en) | 2016-09-29 | 2018-05-31 | Garti Nissim | Method for selective extraction of cannabinoids from a plant source |
IL248149B (en) | 2016-09-29 | 2020-03-31 | Garti Nissim | Dilutable formulations of cannbinoids and processes for their preparation |
CN108143672A (en) * | 2018-03-07 | 2018-06-12 | 安徽心缘康生物科技有限公司 | A kind of lotion containing tree peony extracting solution and preparation method thereof |
CN111481485A (en) * | 2020-06-15 | 2020-08-04 | 西北农林科技大学 | Peony bacteriostatic moisturizing hand cream and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5823612A (en) * | 1981-08-04 | 1983-02-12 | Osaka Chem Lab | Cosmetic composition containing crude drug component |
JPS6087224A (en) * | 1983-10-18 | 1985-05-16 | Pola Chem Ind Inc | Emulsion-type dermatic drug for external use |
JPH10194916A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH11228339A (en) * | 1998-02-13 | 1999-08-24 | Ichimaru Pharcos Co Ltd | Melanin generation suppresser and preparation for external use for skin |
JP2002138014A (en) * | 2000-10-31 | 2002-05-14 | Noevir Co Ltd | Fine emulsion composition |
JP2008290951A (en) * | 2007-05-22 | 2008-12-04 | Mikimoto Pharmaceut Co Ltd | Emulsion composition |
CN101396344A (en) * | 2008-10-28 | 2009-04-01 | 中国人民解放军第二军医大学 | Paeonol microemulsion preparation and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10333245C5 (en) * | 2003-07-21 | 2015-02-19 | Henkel Ag & Co. Kgaa | Prebiotic plant extracts |
CN101185638B (en) * | 2004-10-09 | 2011-04-06 | 山西中医学院 | Microemulsion preparation and preparation method thereof |
CN100515385C (en) * | 2005-01-10 | 2009-07-22 | 张凤娟 | Beauty-white frost of peony and preparation method |
TW200744663A (en) * | 2005-07-27 | 2007-12-16 | Showa Denko Kk | Emulsified skin external preparation and method for stabilizing the skin external preparation |
CN106491509A (en) * | 2007-04-27 | 2017-03-15 | 欧莱雅 | Beauty treatment skin processing method and skin nursing cosmetic product |
-
2011
- 2011-09-30 CN CN201110296131.5A patent/CN103027863B/en active Active
-
2012
- 2012-03-27 WO PCT/CN2012/000379 patent/WO2013044579A1/en active Application Filing
- 2012-03-27 JP JP2014532216A patent/JP5963868B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5823612A (en) * | 1981-08-04 | 1983-02-12 | Osaka Chem Lab | Cosmetic composition containing crude drug component |
JPS6087224A (en) * | 1983-10-18 | 1985-05-16 | Pola Chem Ind Inc | Emulsion-type dermatic drug for external use |
JPH10194916A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH11228339A (en) * | 1998-02-13 | 1999-08-24 | Ichimaru Pharcos Co Ltd | Melanin generation suppresser and preparation for external use for skin |
JP2002138014A (en) * | 2000-10-31 | 2002-05-14 | Noevir Co Ltd | Fine emulsion composition |
JP2008290951A (en) * | 2007-05-22 | 2008-12-04 | Mikimoto Pharmaceut Co Ltd | Emulsion composition |
CN101396344A (en) * | 2008-10-28 | 2009-04-01 | 中国人民解放军第二军医大学 | Paeonol microemulsion preparation and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
JPN6015010367; 原節子他: '水素添加リン脂質の性状に関する研究(第2報)-水素添加リン脂質の乳化性の評価-' 成蹊大学工学報告 第51号, 19910120, 3449〜3458頁, 成蹊大学工学部 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113164366A (en) * | 2018-11-19 | 2021-07-23 | 株式会社Lg生活健康 | Composition for stabilizing poorly soluble component and cosmetic composition containing same |
JP2022509092A (en) * | 2018-11-19 | 2022-01-20 | エルジー ハウスホールド アンド ヘルスケア リミテッド | A composition for stabilizing a sparingly soluble component and a cosmetic composition containing the same. |
JP7384518B2 (en) | 2018-11-19 | 2023-11-21 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Composition for stabilizing poorly soluble ingredients and cosmetic compositions containing the same |
CN113164366B (en) * | 2018-11-19 | 2024-04-19 | 株式会社Lg生活健康 | Composition for stabilizing poorly soluble component and cosmetic composition containing same |
Also Published As
Publication number | Publication date |
---|---|
JP5963868B2 (en) | 2016-08-03 |
CN103027863B (en) | 2015-02-25 |
CN103027863A (en) | 2013-04-10 |
WO2013044579A1 (en) | 2013-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5963868B2 (en) | Microemulsion containing button extract and its preparation method and application | |
KR101470632B1 (en) | Cosmetic Preparation and Method for Preparing the Same | |
CN105585601B (en) | Anti-aging composition for external application and its manufacturing method | |
CN110101593A (en) | A kind of anti-wrinkle cream and preparation method thereof | |
KR20160127823A (en) | Melanogenesis Inhibitor Comprising D-Pantothenyl Alcohol, and Skin-Whitening Cosmetic Containing Same Melanogenesis Inhibitor | |
TW492865B (en) | Composition for enhancing hyaluronic acid productivity and method for preparing same | |
KR102020828B1 (en) | Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof | |
JP2020193198A (en) | Fermented extract of aerial parts of bitter orange | |
KR102016062B1 (en) | Callus extracts from Citrus junos Siebold ex Tanaka and Pyrus pyrifolia Nakai with Whitening and Anti-wrinkle effect | |
KR101648148B1 (en) | Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same | |
KR20220118660A (en) | Whitening cosmetic composition comprising natural extract | |
JP2009179642A (en) | External preparation for skin | |
JP6377879B1 (en) | Topical skin preparation | |
JP2023026622A (en) | Skin external composition | |
KR101878941B1 (en) | Method for producing nanoemulsion containing cultivated wild ginseng fermentate and cosmetic composition for skin whitening comprising the nanoemulsion | |
CN108135823A (en) | Anti-aging comprising carnosine, soybean peptide and Andrographis Paniculata uses composition | |
JP2016187324A (en) | Screening method for skin sagging improver | |
JP7246125B2 (en) | Epidermal cell activator | |
JP2004323468A (en) | Skin care preparation for external use | |
JP6356944B2 (en) | Claudin production promoter, occludin production promoter, tight junction function enhancer | |
KR102622004B1 (en) | Cosmetics for skin whitening or wrinkle improvement comprising chlorella protothecoides extracts and method for preparing the same | |
JP4994684B2 (en) | Moisturizer, cell activator, and antioxidant | |
CN107898931A (en) | A kind of regulator of clock gene expression quantity and preparation method thereof | |
KR102606380B1 (en) | Composition for enhancing skin barrier containing Bolboschoenus planiculmis extract | |
JP2003292418A (en) | Skin care preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140417 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150309 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150320 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150622 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151217 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160315 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160415 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160516 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160614 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160628 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5963868 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |